24/7 Emergency & General Advisory
π¨ 24/7 Medical Emergency
Non-Emergency Advisory
10:00 AM β 6:00 PM, MonβSat
For appointments & general queries.
Join our healthcare community
Stay updated with our latest healthcare news and your appointments.
An in-depth guide to Benlysta (belimumab) for lupus management in India, covering its mechanism, uses, administration, side effects, and precautions.
Lupus is a chronic autoimmune disease that can affect various parts of the body, causing inflammation and pain. For many individuals in India, managing lupus has been a challenging journey. Fortunately, advancements in medical science have brought forth new treatment options like Benlysta (belimumab). This guide aims to provide a clear and practical understanding of Benlysta, its uses, benefits, and considerations for patients in India.
Benlysta, with the active ingredient belimumab, is a type of medication known as a biologic. Specifically, it is a human monoclonal antibody. Biologics are complex drugs derived from living sources, designed to target specific parts of the immune system. Benlysta works by targeting a protein called B-lymphocyte stimulator (BLyS). In lupus, an overactive immune system produces harmful autoantibodies that attack the body's own tissues. BLyS plays a role in the survival and function of B-cells, which are responsible for producing these autoantibodies. By blocking BLyS, Benlysta helps to reduce the number of these harmful autoantibodies, thereby controlling the inflammation and symptoms associated with lupus.
Benlysta is approved for the treatment of certain types of lupus in adults and in children aged 5 years and older. In India, it is primarily used for:
It's important to note that Benlysta is typically used in conjunction with other lupus medications, as prescribed by your doctor. Your healthcare provider will assess your specific condition and determine the most appropriate treatment plan for you.
Benlysta can be administered in two main forms:
The dosage and frequency of administration will depend on the type of lupus being treated, the patient's age, weight, and response to the medication. Your doctor will decide the best method and schedule for you.
Like all medications, Benlysta can cause side effects. It is crucial to be aware of these and to report any concerns to your doctor promptly. Common side effects observed in clinical trials include:
Serious Side Effects: While less common, serious side effects can occur. These may include severe infections, allergic reactions, or a rare but serious condition called progressive multifocal leukoencephalopathy (PML). If you experience any signs of severe infection (e.g., high fever, persistent cough, shortness of breath, burning urination) or any signs of an allergic reaction (e.g., rash, hives, swelling of the face or throat, difficulty breathing), seek immediate medical attention.
Before starting Benlysta treatment, it is essential to discuss your complete medical history with your doctor, including any:
Vaccinations: You should not receive any live vaccines during Benlysta treatment or for at least 30 days before starting treatment. Live vaccines contain weakened forms of viruses or bacteria and can cause serious infections in individuals with a weakened immune system. Discuss your vaccination status with your doctor.
Pregnancy and Breastfeeding: If you are pregnant, planning to become pregnant, or breastfeeding, inform your doctor. The effects of Benlysta during pregnancy and breastfeeding are not fully known, and a risk-benefit assessment will be necessary.
It is crucial to maintain regular follow-up appointments with your doctor while on Benlysta. Contact your doctor immediately if you:
If you experience severe symptoms after an injection, such as difficulty breathing, chest pain, or swelling of the face, seek emergency medical help by calling 108 (India's emergency number) or going to the nearest hospital.
Benlysta begins to work soon after the first dose. However, it may take a few doses before you notice significant improvements in your lupus symptoms. Your doctor will monitor your response to the treatment.
Yes, Benlysta is typically a long-term treatment. If your doctor finds it safe and effective for you, you will likely continue using it for an extended period to manage your lupus.
No, Benlysta is not a chemotherapy drug. It is a biologic medication belonging to a class called monoclonal antibodies. Chemotherapy drugs work by killing rapidly dividing cells, which can include both cancerous and healthy cells. Benlysta, on the other hand, works by specifically targeting certain components of the immune system involved in lupus.
Benlysta is often used alongside other medications to manage lupus. Your doctor will determine the best combination of drugs for your treatment plan. Always inform your doctor about all the medications, supplements, and herbal products you are currently taking.
Benlysta represents a significant advancement in the management of lupus, offering a targeted approach to control this complex autoimmune disease. For patients in India, understanding how Benlysta works, its administration, potential side effects, and necessary precautions is vital for a successful treatment journey. Always rely on your healthcare provider for personalized medical advice and treatment decisions. With proper management and regular medical consultation, individuals with lupus can lead more comfortable and fulfilling lives.
Visit Hospital
Near You

Can a simple blood draw really predict dementia decades before memory problems start? In 2026, several major studies said yes β one found a protein called p-tau217 predicted risk up to 25 years ahead in women, while another found a 78% risk of cognitive impairment within 10 years in people with the
July 23, 2026

Learn about Parkinson's disease symptoms, causes, stages, and treatment options. A complete guide for patients and caregivers in simple language.
June 13, 2026
Seeking a brain specialist in Kamarhati? Doctar connects you with leading neurologists and neurosurgeons for expert care. Book appointments now.
May 20, 2026